Search
Flurazepam
go.drugbank.com/drugs/DB00690ApprovedIllicitA benzodiazepine derivative used mainly as a hypnotic.
CDX-1135
go.drugbank.com/drugs/DB17607InvestigationalCDX-1135, formerly TP-10, is a soluble, recombinant human Complement Receptor Type 1 (sCR1) developed by Avant Immunotherapeutics (now Celldex).
AAV-AIPL
go.drugbank.com/drugs/DB17857ExperimentalDeveloped by MeiraGTx, it is being investigated for the treatment of inherited retinal dystrophy due to defects in _AIPL1_ gene.
TM30339
go.drugbank.com/drugs/DB05085ExperimentalTM30339 works through the same receptor as the natural satiety hormone, Pancreatic Polypeptide (PP), but TM30339 has improved properties compared with PP.
Poa annua pollen
go.drugbank.com/drugs/DB10353ApprovedPoa annua pollen is the pollen of the Poa annua plant. Poa annua pollen is mainly used in allergenic testing.
Categories: Non-Standardized Pollen Allergenic ExtractDistichlis spicata pollen
go.drugbank.com/drugs/DB10494ApprovedDistichlis spicata pollen is the pollen of the Distichlis spicata plant. Distichlis spicata pollen is mainly used in allergenic testing.
Categories: Non-Standardized Pollen Allergenic ExtractUrochloa mutica pollen
go.drugbank.com/drugs/DB10716ApprovedUrochloa mutica pollen is the pollen of the Urochloa mutica plant. Urochloa mutica pollen is mainly used in allergenic testing.
Categories: Non-Standardized Pollen Allergenic ExtractMM-093
go.drugbank.com/drugs/DB05512InvestigationalMM-093 is a recombinant version of human alpha-fetoprotein (hAFP), an immunomodulatory serum protein normally produced at very high levels by the fetus and present in low levels in the blood of adults … Research on AFP suggests that it may play a role in modulating the immune system of the mother in order to protect the developing fetus during pregnancy.
Melarsomine
go.drugbank.com/drugs/DB11528ExperimentalVet approvedMelarsomine is a trypanocidal agent marketed by Merial under the trade name Immiticide. … It is the only FDA-approved treatment for adult heartworm infection in dogs, however, is is not approved for use in dogs with late-stage infection.
AAV1-FS344
go.drugbank.com/drugs/DB17855InvestigationalAAV1-FS344 is an investigational gene therapy developed by Milo Biotechnology to deliver follistatin, a potent myostatin inhibitor.